Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-08-02
2011-08-02
Shiao, Rei-tsang (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S358000
Reexamination Certificate
active
07989454
ABSTRACT:
Provided herein are compounds of the formula (I):as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, COPD.
REFERENCES:
patent: 5457124 (1995-10-01), Cohen et al.
Prostaglandins, Leukotrienes and Essential Fatty Acids 69, 2003, 123-13.
Bioorganic&Medicinal Chemistry Letters1994, 4, 2883-8.
Dominique Romyr
Goodnow, Jr. Robert Alan
Kowalczyk Agnieszka
Qiao Qi
Sidduri Achyutharao
Hoffmann-La Roche Inc.
Johnston George E.
Megerditchian Samuel H.
Shiao Rei-tsang
Tramaloni Dennis P.
LandOfFree
Leukotriene B4 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Leukotriene B4 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Leukotriene B4 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2719476